Event-Driven Stocks

Accelerate Diagnostics, Inc

AXDX

Healthcare · Laboratory Analytical Instruments · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs2 good5 warning3 severedetails ↓

Financials

SEC XBRL · annual
 FY24FY23FY22FY21FY20FY19
Revenue$11.7M$12.1M$12.8M$11.8M$11.2M$9.3M
Operating income−$35.3M−$54.0M−$62.8M−$71.6M−$63.7M−$72.8M
Net income−$50.0M−$61.6M−$62.5M−$77.7M−$78.2M−$84.3M
Total assets$28.6M$31.4M$65.0M$83.0M$93.4M$134.4M
Total liabilities$84.6M$51.3M$87.3M$118.1M$156.2M$141.8M
Equity−$56.0M−$19.9M−$22.3M−$35.1M−$62.9M−$7.4M
EPS (diluted)$-2.15$-4.94$-7.61$-12.59$-1.40$-1.55
Shares out.21.7M99.6M67.8M59.3M54.9M54.4M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2024
Operating margin
−301.8%
Net margin
−427.8%
Return on equity
89.3%
Return on assets
−175.3%
Return on capital (ROCE)
Liabilities / assets
296.2%
Debt / equity
Book value / share
$-2.59
Revenue growth (YoY)
−3.0%
Net income growth (YoY)

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2024
Altman Z″ (distress)
-93.13distress
Accruals / assets
90.5%clean
Beneish M-Score
-7.22normal
Piotroski F-Score
5/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
25
/ 100
Profitability 25Growth 0Catalyst 33Earnings quality 67Financial strength 0

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

3 severe5 warning2 good
  • Negative shareholder equity
  • Altman Z″ in the distress zone
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Revenue declined year-over-year
  • High leverage (liabilities > 70% of assets)
  • Negative operating cash flow
  • Strong return on equity (>15%)
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
Apr 30, 2025297,37714.2+1.6%
Apr 15, 2025292,8074.3-18.4%
Mar 31, 2025359,0405.0-15.6%
Mar 14, 2025425,48521.6-3.2%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (3)